Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor

被引:124
|
作者
Hellyer, NJ
Kim, MS
Koland, JG [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA
[2] Chosun Univ, Coll Dent, Dept Pharmacol, Kwangju 501759, South Korea
关键词
D O I
10.1074/jbc.M102079200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ErbB2/ErbB3 heregulin co-receptor has been shown to couple to phosphoinositide (PI) 3-kinase in a heregulin-dependent manner. The recruitment and activation of PI 3-kinase by this co-receptor is presumed to occur via its interaction with phosphorylated Tyr-Xaa-Xaa-Met (YXXM) motifs occurring in the ErbB3 C terminus. In this study, mutant ErbB3 receptor proteins expressed in COS7 cells were used to investigate PI 3-kinase-dependent signaling pathways activated by the ErbB2/ErbB3 co-receptor. We observed that a mutant ErbB3 protein with each of its six YXXM motifs containing a Tyr --> Phe substitution was unable to bind either the p85 regulatory or p110 catalytic subunit of PI 3-kinase. However, restoration of a single YXXM motif was sufficient to mediate association with the PI 3-kinase holoenzyme, although at a lower level han wild-type ErbB3. When ErbB3 YXXM motifs were restored in pairs, evidence for cooperativity between two, those incorporating Tyr-1273 and Tyr-1286, was observed. Interestingly, we have shown that an apparent association of PI 3-kinase activity with ErbB2/Neu was due to the residual presence of ErbB3 in ErbB2 immunoprecipitates. The necessity of ErbB3 association with PI 3-kinase for downstream signaling to the effector kinase Akt was also investigated. Here, the heregulin-dependent translocation of Akt to the plasma membrane and its subsequent activation was observed in intact NIH-3T3 fibroblasts. Recruitment of PI 3-kinase to ErbB3 was required for both activities, and it appeared that ErbB2 activation alone was not sufficient to activate PI 3-kinase signaling in these cells.
引用
收藏
页码:42153 / 42161
页数:9
相关论文
共 50 条
  • [31] Expression and activation of ErbB2, ErbB3, and their ligand, neuregulin during sciatic nerve regeneration
    Cheon, K
    Kim, M
    Marchionni, MA
    Kwon, YK
    [J]. JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S11 - S11
  • [32] Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
    Loree, Jonathan M.
    Bailey, Ann M.
    Johnson, Amber M.
    Yu, Yao
    Wu, Wenhui
    Bristow, Christopher A.
    Davis, Jennifer S.
    Shaw, Kenna R.
    Broaddus, Russell
    Banks, Kimberly C.
    Lanman, Richard B.
    Meric-Bernstam, Funda
    Overman, Michael J.
    Kopetz, Scott
    Raghav, Kanwal
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (12) : 1409 - 1417
  • [33] Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
    José Baselga
    Sandra M. Swain
    [J]. Nature Reviews Cancer, 2009, 9 : 463 - 475
  • [34] Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3
    Sak, Malgorzata Magdalena
    Szymanska, Monika
    Bertelsen, Vibeke
    Hasmann, Max
    Madshus, Inger Helene
    Stang, Espen
    [J]. CARCINOGENESIS, 2013, 34 (09) : 2031 - 2038
  • [35] ERBB3 IS INVOLVED IN ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE BY EPIDERMAL GROWTH-FACTOR
    SOLTOFF, SP
    CARRAWAY, KL
    PRIGENT, SA
    GULLICK, WG
    CANTLEY, LC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) : 3550 - 3558
  • [36] Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
    Baselga, Jose
    Swain, Sandra M.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (07) : 463 - 475
  • [37] Upregulation of erbB2/erbB3 and enhanced signal transduction via the phosphatidylinositol 3-kinase pathway in a tamoxifen-resistant breast cancer cell line.
    Pancholi, S
    Martin, LA
    Lykkesfeldt, AE
    Dowsett, M
    Johnston, SRD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S165 - S165
  • [38] Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors
    Todd D. Camenisch
    Joyce A. Schroeder
    Judy Bradley
    Scott E. Klewer
    John A. McDonald
    [J]. Nature Medicine, 2002, 8 : 850 - 855
  • [39] Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2–ErbB3 complex in their active conformations
    Juan Felipe Franco-Gonzalez
    Javier Ramos
    Victor L. Cruz
    Javier Martínez-Salazar
    [J]. Journal of Molecular Modeling, 2013, 19 : 931 - 941
  • [40] ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase
    [J]. Biochemical Journal, 1998, 333 (pt 3): : 757 - 763